Two biotechnology companies — and a host of other companies and research institutions — are awaiting a federal ruling on antisense technology patent rights.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steele, F. Antisense patent trial wraps up. Nat Med 1, 389 (1995). https://doi.org/10.1038/nm0595-389a
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0595-389a
This article is cited by
-
Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game?
Kidney International (1997)